Healthcare Solutions

May 1, 2018

Looking beyond the ‘magic bullet’ approach to drug discovery

Vanderbilt scientists have developed a new process that can rapidly and inexpensively identify personalized cancer drugs derived from nature.

By VUMC News and Communications

Elderly caucasian woman with her hands on a cane

February 12, 2018

‘Smart cane’ could one day help flag gait problems, falling risks more quickly

Falling is no joke when you’re a senior citizen or have other balance issues. Vanderbilt engineers are working on a ‘smart cane’ that could help physical therapists spot and treat problems sooner.

By VUMC News and Communications

January 8, 2018

Vanderbilt signs licensing, research agreements to develop new approach to schizophrenia treatment

Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia.

By Bill Snyder

November 30, 2017

Study seeks to reduce opioid use for chronic pain

Kristin Archer, PhD, DPT, associate professor and vice chair of Orthopaedics and Rehabilitation, will serve as principal investigator at Vanderbilt University Medical Center (VUMC) for a clinical trial that is examining strategies for reducing opioid use among patients with chronic pain.

By Tom Wilemon

October 3, 2017

Cell signals that trigger wound healing are surprisingly complex

Vanderbilt scientists have taken an important step toward understanding the way in which injured cells trigger wound healing, an insight essential for improving treatments of all types of wounds.

By VUMC News and Communications

Pediatric health conditions, their treatments and the related stress hinder the prefrontal cortex, which is the region of the brain associated with learning, memory and behavior. (istock)

September 20, 2017

Goal of new tissue-chip research is to assess efficacy of novel epilepsy drugs

An interdisciplinary team of Vanderbilt University researchers has received a two-year, $2-million federal grant to develop an “organ-on-chip” model for two genetic forms of epilepsy.